OVERVIEW

This course is a result of the collaboration Between ADA and Mankind Pharma to benefit millions of people living with diabetes in India. This collaboration is aimed at a mission to prevent diabetes and improve the lives of all people affected by diabetes in India through health care professional education. Diabetes is a major cause of heart attacks, stroke, kidney failure and lower limb amputation around the world. Primary health care professionals stand on the frontline of care delivery for the 422+ million individuals living with diabetes around the world with over 77 million people with diabetes living in India.

LEARNING OBJECTIVES

• Recognize risk factors, pathophysiology, and advances in early detection and treatment of diabetes-related complications, such as vision loss and neuropathy.
• Examine the role of screening for diabetes-related complications in asymptomatic people with diabetes and people with kidney or cardiovascular disease.
• Identify the pathophysiology and risk factors of chronic kidney disease and cardiovascular disease in diabetes.  
• Recall screening and monitoring best practices for chronic kidney and cardiovascular disease in diabetes.  
• Recall the role of new agents, SGLT2 inhibitors and GLP-1 RA, in mitigating cardiorenal risk.

CREDITS AND BENEFITS

• TBD Free CE (CME, ABIM-MOC, ACPE, ANCC, AAPA, CDR, COP)
• Three self-paced modules.
• Each module includes an expert discussing their perspective in terms of the condition in India.

EXPIRATION DATE

August 20, 2026

This program is supported, in part, by an unrestricted educational grant from Mankind Pharma Limited.

Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!